Skip to main content

Table 3 Scoliosis severity with respect to genotypes

From: Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients

 

Scoliosis severity

Row summary

P value

Non-scoliotic

Mild

Moderate

Severe

No. of patients

85

106

40

59

n = 290

 

Gender

0.262

Female

38

39

18

31

n = 126

 

Male

47

67

22

28

n = 164

 

Max Cobb angles (°)

0.6 ± 2.2

15.2 ± 3.7

34.8 ± 7.5

82.3 ± 22.9

27.3 ± 31.7

< 0.001

Mean age at Max Cobb (years)

8.4 ± 8.7

10.6 ± 6.4

15 ± 7.8

17.9 ± 6.3

12.0 ± 8.1

< 0.001

Sites of scoliosis apex of the major curve

0.068

T1–T2

0

0

0

0

n = 0

 

T3–T4

0

0

1

2

n = 3

 

T5–T6

0

9

4

7

n = 20

 

T7–T8

0

16

10

20

n = 46

 

T9–T10

0

25

6

11

n = 42

 

T11–T12

0

26

6

10

n = 42

 

L1–L2

0

29

11

9

n = 49

 

L3–L4

0

1

2

0

n = 3

 

L5

0

0

0

0

n = 0

 

Number of curves per patient, among the 205 patients with scoliosis

< 0.001

1 curve

0

102

30

37

n = 169

 

2 curves

0

4

10

21

n = 35

 

3 curves

0

0

0

1

n = 1

 

Autosomal dominant (AD)

0.422a

COL1A1

23

29

11

13

n = 76

 

(Qualitative)

(10)

(15)

(7)

(9)

(n = 41)

0.438b

(Quantitative)

(13)

(14)

(4)

(4)

(n = 35)

 

COL1A2

27

27

8

7

n = 69

 

(Qualitative)

(22)

(19)

(8)

(7)

(n = 56)

0.136c

(Quantitative)

(5)

(8)

(0)

(0)

(n = 13)

 

IFITM5

3

7

3

5

n = 18

 

(All singleton AD)

(53)

(63)

(22)

(25)

(n = 163)

 

AD-compound

COL1A1, COL1A2

0

0

0

1

n = 1

 

IFITM5, COL1A1

0

1

0

1

n = 2

 

Autosomal recessive (AR) or AR/AD-compound

WNT1

5

5

4

6

n = 20

 

SERPINF1

1

4

2

2

n = 9

 

FKBP10

0

3

1

2

n = 6

 

P3H1

0

1

0

1

n = 2

 

BMP1

0

0

0

1

n = 1

 

SERPINH1

1

0

0

0

n = 1

 

(All singleton AR)

(7)

(13)

(7)

(12)

(n = 39)

 

AR/AD-compound

COL1A1, COL1A2, BMP1

0

0

0

1

n = 1

 

FKBP10, COL1A1

0

0

0

1

n = 1

 

SEC24D, COL1A1

1

0

0

0

n = 1

 

No mutationd

3

4

3

3

n = 13

 

Not tested

21

25

8

15

n = 69

 
  1. aBetween severity grades and the three AD genes
  2. bBetween severity grades and the mutation types (quantitative or qualitative), within the COL1A1 patients
  3. cBetween severity grades and the mutation types (quantitative or qualitative), within the COL1A2 patients
  4. dNo mutation on the 18 OI risk genes tested in the current study. Plus–minus values are means ± SD